Escaped prison inmates pretended to be migrants, asked to be deported
https://www.azcentral.com/story/news/politics/border-issues/2020/05/28/colorado-fugitives-found-arizona-mexico-border-pretended-immigrants/5279602002/
911 call from Breonna Taylor's shooting death released: "Somebody kicked in the door and shot my girlfriend"
On the night 26-year-old emergency medical worker Breonna Taylor was shot and killed by police inside her home, her boyfriend, Kenneth Walker, told a 911 operator that "somebody kicked in the door and shot my girlfriend." Taylor's death has sparked national outcry and an FBI investigation.
"I don't know what happened … somebody kicked in the door and shot my girlfriend," Walker told the dispatcher. When asked where Taylor had been shot, Walker replied, "I don't know, she is on the ground right now. I don't know, I don't know."
He added that Taylor was unresponsive, yelling "Help!" and "Oh my God," throughout the two-minute call. The audio of the call was released by an attorney for Taylor's family, CBS affiliate WLKY-TV reported.
https://www.cbsnews.com/news/breonna-taylor-killed-by-police-kenneth-walker-911-call-released/
4 am talking point?
The Trump Administration Totally Botched Its Distribution Of COVID-19 Treatment to Hospitals
https://www.vanityfair.com/news/2020/05/trump-administration-botched-remdesivir-distribution-to-hospitals-covid19
President Donald Trump and his allies have long hyped the anti-malaria drug hydroxychloroquine when it comes to treating COVID-19, despite a lack of evidence showing the drug’s effectiveness as a coronavirus treatment and studies showing it may cause a higher risk of death. But while hydroxychloroquine may be an unreliable solution to the coronavirus crisis, there’s one drug that the Food and Drug Administration has actually approved for emergency use in treating COVID-19: remdesivir, an antiviral medication that some studies have suggested may be effective in fighting the coronavirus. With coronavirus patients across the country desperately in need of the drug, however, the demand is quickly outstripping the supply—and in the drug’s initial rollout to hospitals, the Trump administration reportedly couldn’t even successfully distribute the limited quantities of the drug that they had.
The Washington Post reports that after drug manufacturer Gilead Sciences donated 607,000 vials of remdesivir to the federal government, the Trump administration’s distribution of the first tranche of medication in early May left much to be desired. The drug was reportedly sent to facilities in 13 states, but without consulting state officials to determine where the medication should go. As a result, remdesivir was sent to hospitals without intensive care units (and thus, without patients eligible to receive the drug); hospitals without the proper facilities to properly refrigerate the drug in order to store it—and, in some cases, just the wrong hospitals altogether. Hospitals were also not alerted ahead of time that they would be given the drug, leaving many unprepared to receive it.